ABSTRACT
Background: To highlight the clinical presentations and management outcomes of rhino-orbital mucormycosis during first wave of COVID-19 pandemic in North India. Methods: A retrospective observational study. 15 patients with mucormycosis (orbital disease) who presented during short span of 3 months (October-December 2020) in a tertiary-care referral institution were analysed. Results: At presentation, 13 of 15 patients had uncontrolled diabetes. Four had history of COVID-19 infection. All patients had advanced orbital disease with sinusitis; cavernous sinus involvement was in nine and intracranial spread in three patients. Liposomal amphotericin-B was started and prompt orbital exenteration with sinus surgery was performed in 12 patients. All 12 patients survived with an average follow-up of 4.8 months. Conclusion: In the present series, cases with orbital spread of mucormycosis were mostly found in non-COVID uncontrolled diabetics. Exenteration was done in 80% of cases with advanced orbital disease. Prevention and early detection of infection at the stage of sino-nasal involvement might help to prevent spread and/or halt the orbital disease.
ABSTRACT
Telemedicine is an important tool improving the delivery of health care services for diagnosis, treatment and prevention of diseases. A 22-year-old female consulted over video teleconsultation for a swelling in the left upper eyelid, which also moved at certain times for eight days. The video revealed a vermiform swelling on her left upper eyelid with occasional movements. A provisional diagnosis of subcutaneous eyelid Dirofilaria infection was made, and with the help of a surgeon practising locally, it was removed in total. The worm was 40 mm in length and had a slender white body, identified as a sexually immature female Dirofilaria repens. Herein, we share this exciting experience of diagnosing subcutaneous eyelid dirofilariasis at a telemedicine video conference.